Executive Order Directs HHS to Strengthen Medicaid Drug Rebate Accuracy and State Cost Management Tools

A new executive order from President Trump instructs federal agencies to develop recommendations within 180 days for improving Medicaid drug rebate accuracy, advancing value-based payment arrangements for pharmaceuticals, and supporting state-level strategies to manage drug spending. While much of the order focuses on Medicare reforms—including changes to IRA negotiation guidance and new CMMI pricing models—the Medicaid provisions signal potential federal action that could reshape how MCOs and states approach pharmacy benefit design and financial management. The directive suggests increased federal attention to pharmacy cost containment as a priority area for Medicaid managed care plans.

Pharmacy · Managed Care · Finance

This is outside commentary from Avalere, not part of Medicaid Monitor's independently scored news coverage.

More from Avalere